logo

For the Inventor, By the Inventor

Kfar Qassem, Israel

Osnat Sella-Tavor

This inventor holds 16 USPTO granted patents and 11 published patent applications and 4 EPO patents. Top assignees: Compugen Ltd. Corporation, Given Imaging Ltd.. Active years: 2008-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Osnat Sella-Tavor. Retrieved from https://idiyas.com/inventor/osnat-sella-tavor

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 

% Patents Active = 18.8

 

Average Co-Inventor Count = 8.4

ph-index = 6

Forward Citations = 292(Granted Patents)


Location History:

  • Gat Rimon, IL (2009 - 2010)
  • Kfar Kish, IL (2008 - 2020)

Company Filing History:

goldMedal13 out of 62 
 
Compugen Ltd. Corporation
 patents
silverMedal3 out of 286 
 
Given Imaging Ltd.
 patents

Years Active: 2008-2020

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 10827953 - Devices, systems and methods for in-vivo immunoassay (2020-11-10),
2. 9347952 - Soluble VEGFR-1 variants for diagnosis of preeclampsia (2016-05-24),
3. 8911368 - Device, system and method for detection of bleeding (2014-12-16),
4. 8515507 - Device and method for detecting in-vivo pathology (2013-08-20),
5. 7939634 - Polynucleotides encoding polypeptides and methods using same (2011-05-10),
6. 7906635 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer (2011-03-15),
7. 7842459 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis (2010-11-29),
8. 7741433 - Diagnostic markers, especially for in vivo imaging and assays and methods of use thereof (2010-06-22),
9. 7714100 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease (2010-05-11),
10. 7667001 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer (2010-02-23),
11. 7569662 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer (2009-08-04),
12. 7553948 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer (2009-06-30),
13. 7528243 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer (2009-05-05),
14. 7488813 - Diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof (2009-02-10),
15. 7368548 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer (2008-05-06),

Sure, here is an article about inventor Osnat Sella-Tavor:

Title: Innovator Spotlight: Osnat Sella-Tavor

Introduction:

Osnat Sella-Tavor, a talented inventor hailing from Kfar Kish, Israel, has made significant contributions in the field of medical devices and molecular diagnostics. With an impressive portfolio of 16 patents, his innovative work has paved the way for groundbreaking advancements in in-vivo immunoassay and the diagnosis of conditions such as preeclampsia.

Latest Patents:

One of his recent patents includes devices, systems, and methods for in-vivo immunoassay. This invention features a swallowable in-vivo device equipped with a lateral flow arrangement for absorbing fluid and a sensor for detecting changes caused by interaction with the fluid. Another notable patent is on soluble VEGFR-1 variants for the diagnosis of preeclampsia, showcasing his expertise in molecular diagnostics.

Career Highlights:

Osnat Sella-Tavor has held key positions at renowned companies such as Compugen Ltd. and Given Imaging Ltd. His innovative spirit and dedication to research have led to the development of cutting-edge technologies that have the potential to revolutionize the healthcare industry.

Collaborations:

Throughout his career, Osnat Sella-Tavor has collaborated with esteemed professionals in the field, including coworkers Sarah Rachel Pollock and Shirley Sameah-Greenwald. Together, they have worked on projects that have pushed the boundaries of scientific innovation and contributed to the growth of the medical device industry.

Conclusion:

In conclusion, Osnat Sella-Tavor stands out as a visionary inventor who continues to make significant strides in the field of medical technology. His relentless pursuit of innovation and commitment to improving healthcare outcomes underscore his impact as a pioneering figure in the industry. Osnat Sella-Tavor's work serves as a testament to the power of creativity and ingenuity in driving positive change in the world of inventions and patents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…